Jolanta Airey
Förmögenhet: - $ per 2026-07-31
Förmögenhet: - $ per 2026-07-31
Dr. Jolanta Airey was previously employed as a Chief Medical Officer by Cynata Therapeutics Ltd., a Director-Translational Development by CSL Ltd., and a Head-Clinical Development Physician by CSL Seqirus Inc. She received her doctorate degree from Vilnius University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-30 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ACRUX LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2026-08-24 |
| Företag | Position | Slut |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2026-01-01 |
| CSL LIMITED | Företagsledare/Principal | 2021-10-01 |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån